Cargando…
Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ESMO Open
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682357/ https://www.ncbi.nlm.nih.gov/pubmed/29147577 http://dx.doi.org/10.1136/esmoopen-2016-000119 |
_version_ | 1783278083858497536 |
---|---|
author | Vansteenkiste, Johan |
author_facet | Vansteenkiste, Johan |
author_sort | Vansteenkiste, Johan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5682357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | ESMO Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-56823572017-11-16 Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis Vansteenkiste, Johan ESMO Open Editorial ESMO Open 2017-03-07 /pmc/articles/PMC5682357/ /pubmed/29147577 http://dx.doi.org/10.1136/esmoopen-2016-000119 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Editorial Vansteenkiste, Johan Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis |
title | Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis |
title_full | Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis |
title_fullStr | Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis |
title_full_unstemmed | Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis |
title_short | Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis |
title_sort | nivolumab for nsclc in japanese patients: similar benefits, but beware of pneumonitis |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682357/ https://www.ncbi.nlm.nih.gov/pubmed/29147577 http://dx.doi.org/10.1136/esmoopen-2016-000119 |
work_keys_str_mv | AT vansteenkistejohan nivolumabfornsclcinjapanesepatientssimilarbenefitsbutbewareofpneumonitis |